Effect of mattress encasings on atopic dermatitis outcome measures in a double-blind, placebo-controlled study: the Dutch mite avoidance study
- PMID: 12209102
- DOI: 10.1067/mai.2002.126791
Effect of mattress encasings on atopic dermatitis outcome measures in a double-blind, placebo-controlled study: the Dutch mite avoidance study
Abstract
Background: House dust mite (HDM) allergen might induce and maintain atopic dermatitis (AD). Reduction of allergen load by applying encasings might improve the clinical symptoms of AD.
Objective: We sought to investigate, in a randomized, double-blind, placebo-controlled study, whether reducing HDM allergen levels by using mattress, duvet, and pillow encasings for 12 months will result in improvement in AD symptoms.
Methods: Patients with AD (8-50 years old and allergic to HDM), having a Leicester sign score (a dermatitis score) of at least 1% extent and a severity score of 6 points or greater, were randomly allocated to an active (n = 45) or a placebo allergen-avoidance group (n = 41). Avoidance measures consisted of applying HDM-impermeable encasings for mattresses, pillows, and duvets for the active treatment group and cotton encasings for the placebo group. Effect on allergen concentrations (Der p 1 and Der p 1 plus Der f 1), Leicester sign score extent and severity, visual analogue scale scores for itching and sleeplessness, intradermal test results, atopy patch test results, total serum IgE levels, anti-Der p 1-specific IgE levels, and total blood eosinophil counts were studied.
Results: The active encasings reduced the Der p 1 allergen concentration in the mattress after 12 months with a factor 2.1 (P =.007) and the Der p 1 plus Der f 1 allergen concentration with a factor of 2.5 (P =.005); no significant change in allergen concentrations in mattresses was seen in the placebo group. Although the decrease in allergen load was significant, no differences in treatment-induced changes were seen between the placebo and active groups.
Conclusions: Use of HDM-impermeable encasings resulted in a significant decrease in Der p 1 and Der p 1 plus Der f 1 allergen concentrations. However, this reduction in allergen load did not result in significant changes in clinical parameters between the groups. Reduction of allergens in other environments (work, school, and outdoors) might be equally important in improving symptoms of AD.
Comment in
-
Atopic dermatitis and the clinical effect of house dust mite avoidance.J Allergy Clin Immunol. 2003 Jan;111(1):202-3; author reply 203-4. doi: 10.1067/mai.2003.95. J Allergy Clin Immunol. 2003. PMID: 12532125 No abstract available.
Similar articles
-
Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis.Lancet. 1996 Jan 6;347(8993):15-8. doi: 10.1016/s0140-6736(96)91556-1. Lancet. 1996. PMID: 8531541 Clinical Trial.
-
The effect of anti-allergic mattress encasings on house dust mite-induced early- and late-airway reactions in asthmatic patients. A double-blind, placebo-controlled study.Clin Exp Allergy. 2002 Jan;32(1):117-25. doi: 10.1046/j.0022-0477.2001.01256.x. Clin Exp Allergy. 2002. PMID: 12002728 Clinical Trial.
-
Mattress encasings and mite allergen levels in the Prevention and Incidence of Asthma and Mite Allergy study.Clin Exp Allergy. 2003 Apr;33(4):490-5. doi: 10.1046/j.1365-2222.2003.01626.x. Clin Exp Allergy. 2003. PMID: 12680865 Clinical Trial.
-
Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.Pediatr Allergy Immunol. 2004 Jun;15 Suppl 16:4-5, 9-32. doi: 10.1111/j.1399-3038.2004.0148b.x. Pediatr Allergy Immunol. 2004. PMID: 15125698 Review.
-
House-dust mite hypersensitivity, eczema, and other nonpulmonary manifestations of allergy.Allergy. 1998;53(48 Suppl):92-6. doi: 10.1111/j.1398-9995.1998.tb05006.x. Allergy. 1998. PMID: 10096817 Review.
Cited by
-
The diagnosis and graded therapy of atopic dermatitis.Dtsch Arztebl Int. 2014 Jul 21;111(29-30):509-20, i. doi: 10.3238/arztebl.2014.0509. Dtsch Arztebl Int. 2014. PMID: 25142076 Free PMC article. Review.
-
Personalized Immunomodulatory Therapy for Atopic Dermatitis: An Allergist's View.Ann Dermatol. 2015 Aug;27(4):355-63. doi: 10.5021/ad.2015.27.4.355. Epub 2015 Jul 29. Ann Dermatol. 2015. PMID: 26273148 Free PMC article. Review.
-
House dust mite reduction and avoidance measures for treating eczema.Cochrane Database Syst Rev. 2015 Jan 19;1(1):CD008426. doi: 10.1002/14651858.CD008426.pub2. Cochrane Database Syst Rev. 2015. PMID: 25598014 Free PMC article.
-
Consensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part I): General Management and Topical Treatment.Ann Dermatol. 2015 Oct;27(5):563-77. doi: 10.5021/ad.2015.27.5.563. Epub 2015 Oct 2. Ann Dermatol. 2015. PMID: 26512171 Free PMC article.
-
In-vitro diagnostic in atopic dermatitis: Options and limitations.Allergol Select. 2017 Apr 7;1(2):150-159. doi: 10.5414/ALX01549E. eCollection 2017. Allergol Select. 2017. PMID: 30402613 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical